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Introduction:  Little is known regarding the impact of pre-implant left ventricular dilation on the reverse remodelling effects of cardiac 
resynchronization therapy (CRT) in patients with advanced heart failure. 
Methods: We examined clinical, echocardiographic, and laboratory data on 546 consecutive patients undergoing the new implantation of a CRT 
device between 1/7/2005 and 8/6/2007. Patients without a pre-CRT echocardiogram or a US social security number were excluded. Endpoints 
were all-cause mortality and change in ejection fraction (EF). A multivariate model was constructed to evaluate predictors of mortality determined by 
the US Social Security Death Index. Changes in EF were recorded in relation to pre-CRT left ventricular end-diastolic diameter (LVEDD). 
Results: 471 patients met inclusion criteria. The mean EF(%) and LVEDD(cm) were 23.0±8.4 and LVEDD 6.1±1.0, respectively. In multivariate 
analysis, pre-CRT LVEDD remained a strong predictor of overall mortality (HR 1.1-1.9, p=0.017). 334 patients had both pre-CRT and follow up 
echocardiograms at a mean of 13.6±10.9 months. Patients without ventricular dilation experienced the greatest improvement in EF whereas those 
with severe LV dilation, starting at approximately 7.0 cm, had less improvement. 
Conclusion: LVEDD is a strong predictor of mortality in patients undergoing CRT. Patients without ventricular 
dilation have the largest improvements in EF with CRT; whereas patients with severe dilation derive less benefit.
